1.A Case of Spondylometaphyseal Dysplasia ( Kozlowski type ).
Seok Hyun LEE ; Seung Woo SUH ; Kyung Wook RHA ; Hyun Il JUNG ; Jeong Hyeon JO
The Journal of the Korean Orthopaedic Association 1997;32(3):768-772
Spondylometaphyseal dysplasia (SMD) is an extremely rare, which affects the spine and metaphy-ses of the tubular bones on terms of enchondrogenesis. Children who had Kozlowski dwarfism, type of SMD are not recognized until they reach school age since they have normal clinical feature, weight and size in early childhood. Authors experienced a typical case of Kozlowski type of SMD in a 10 years old male who had i) generalized platyspondyly with anterior tapering of vertebrae ii) generalized metaphyseal dysplasia iii) minimal changes in the carpal and tarsal bones. This case is to be reported with review of references.
Child
;
Dwarfism
;
Humans
;
Male
;
Spine
;
Tarsal Bones
2.Two Cases of Symptomatic Prostatic Cysts.
Ji Soo KIM ; Dong Wook KIM ; Kyung Wan GU ; Gong Chan RAH ; Seung Ki MIN ; Moon Ki JO
Korean Journal of Urology 2000;41(12):1554-1557
No abstract available.
3.Preventing the Transmission of Tuberculosis in Health Care Settings: Administrative Control.
Tuberculosis and Respiratory Diseases 2017;80(1):21-26
It is well established that health care workers (HCWs) have a considerably higher risk of occupationally acquired tuberculosis (TB). To reduce the transmission of TB to HCWs and patients, TB infection control programs should be implemented in health care settings. The first and most important level of all protection and control programs is administrative control. Its goals are to prevent HCWs, other staff, and patients from being exposed to TB, and to reduce the transmission of infection by ensuring rapid diagnosis and treatment of affected individuals. Administrative control measures recommended by the United States Centers for Disease Control and Prevention and the World Health Organization include prompt identification of people with TB symptoms, isolation of infectious patients, control of the spread of the pathogen, and minimization of time spent in health care facilities. Another key component of measures undertaken is the baseline and serial screening for latent TB infection in HCWs who are at risk of exposure to TB. Although the interferon-gamma release assay has some advantages over the tuberculin skin test, the former has serious limitations, mostly due to its high conversion rate.
Centers for Disease Control and Prevention (U.S.)
;
Delivery of Health Care*
;
Diagnosis
;
Health Personnel
;
Humans
;
Infection Control
;
Interferon-gamma Release Tests
;
Mass Screening
;
Occupations
;
Skin Tests
;
Tuberculin
;
Tuberculin Test
;
Tuberculosis*
;
World Health Organization
4.One Year Follow-up Result of Doppler-guided Hemorrhoidal Artery Ligation and Recto-Anal Repair in 97 Consecutive Patients.
Wan Jo JEONG ; Sung Wook CHO ; Kyung Tae NOH ; Soon Sup CHUNG
Journal of the Korean Society of Coloproctology 2011;27(6):298-302
PURPOSE: Doppler-guided hemorrhoidal artery ligation and recto-anal repair (DG-HAL & RAR) is known for low recurrence, high patient satisfaction, and less postoperative pain. The purpose of this study is to analyze the 1-year follow-up results in patients who underwent a DG-HAL & RAR and to establish the benefits of the procedure. METHODS: Among the hemorrhoid patients who were admitted to our hospital from March 2008 to May 2010 and who underwent a DG-HAL & RAR, 97 patients who were followed up for a year were investigated. Recurrence, complications, admission period, difference in preoperative and postoperative pain, operation time, and time to return to daily activities were investigated. RESULTS: The average admission period was 1.6 +/- 1.1 days. Pain at postoperative day 7 showed no significant difference from preoperative pain (P > 0.05). The operation time was 34.0 +/- 7.3 minutes on average, and return to daily activities was timed at 2.3 +/- 2.0 days postoperatively. At the one year follow-up, no serious complications were noted, and preoperative symptoms recurred only in 14 patients (14.4%). CONCLUSION: In most patients with hemorrhoids, excluding those with severe prolapsed hemorrhoids, less pain, no serious complications, and good long-term outcome can be expected from a DG-HAL & RAR.
Arteries
;
Follow-Up Studies
;
Hemorrhoids
;
Humans
;
Ligation
;
Pain, Postoperative
;
Patient Satisfaction
;
Recurrence
5.Treatment of Mycobacterium abscessus complex pulmonary disease
Journal of the Korean Medical Association 2024;67(1):26-32
In South Korea, bacteria in the Mycobacterium abscessus complex (MABC), a group of rapidly growing mycobacteria, are second to those in the Mycobacterium avium complex as a cause of non-tuberculous mycobacterial pulmonary disease. The MABC includes several subspecies, including M. abscessus subsp. abscessus (M. abscessus) and M. abscessus subsp. massiliense (M. massiliense), the former of which is difficult to treat owing to its antibiotic resistance.Current Concepts: M. abscessus encodes a functional erythromycin ribosomal methylase gene, erm(41), that causes inducible macrolide resistance. Contrastingly, M. massiliense lacks a functional erm(41) gene owing to a partial deletion. Accordingly, culture conversion rates using currently recommended macrolide-based antibiotic treatments are considerably higher among patients with M. massiliense infection than in those infected with M. abscessus. Phase therapy (intensive and continuous) is recommended for MABC pulmonary disease and, depending on the subspecies and antimicrobial susceptibility test results, should include an initial treatment of ≥3 to 4 injectable and oral antibiotics, followed by inhaled or intravenous amikacin and ≥1 to 2 oral antibiotics. Recommended injectable antibiotics include amikacin, imipenem or cefoxitin, and tigecycline, and oral antibiotics include macrolides (azithromycin or clarithromycin), clofazimine, linezolid, and rifabutin. For some patients, surgery should be considered as an adjunctive treatment option.Discussion and Conclusion: Given that M. abscessus expresses the inducible resistance gene erm(41) associated with macrolide resistance, the identification of MABC subspecies is important for disease management. However, despite the combined application of several injectable/oral antibiotics, the treatment outcomes for M. abscessus pulmonary disease remain unsatisfactory.
6.A case of primary pulmonary cryptococcosis misdiagnosed as lung cancer.
Kyung Shik KOH ; Min Soo HAN ; Hee Doo KYUNG ; Joo Chul PARK ; Ik YANG ; Dong Wook SUNG ; Joo Hee LEE ; Hwan Jo SUH
Korean Journal of Infectious Diseases 1993;25(3):259-264
No abstract available.
Cryptococcosis*
;
Lung Neoplasms*
;
Lung*
7.A case of primary pulmonary cryptococcosis misdiagnosed as lung cancer.
Kyung Shik KOH ; Min Soo HAN ; Hee Doo KYUNG ; Joo Chul PARK ; Ik YANG ; Dong Wook SUNG ; Joo Hee LEE ; Hwan Jo SUH
Korean Journal of Infectious Diseases 1993;25(3):259-264
No abstract available.
Cryptococcosis*
;
Lung Neoplasms*
;
Lung*
8.Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea.
Bo Hyoung KANG ; Kyung Wook JO ; Tae Sun SHIM
Tuberculosis and Respiratory Diseases 2017;80(2):143-152
BACKGROUND: Fluoroquinolones are considered important substitutes for the treatment of tuberculosis. This study investigates the current status of fluoroquinolone for the treatment of tuberculosis. METHODS: In 2009, a retrospective analysis was performed at one tertiary referral center for 953 patients diagnosed with tuberculosis. RESULTS: A total of 226 patients (23.6%), who received fluoroquinolone at any time during treatment for tuberculosis, were enrolled in this study. The most common reasons for fluoroquinolone use were adverse events due to other anti-tuberculosis drugs (52.7%), drug resistance (23.5%), and underlying diseases (16.8%). Moxifloxacin (54.0%, 122/226) was the most commonly administered fluoroquinolone, followed by levofloxacin (36.3%, 82/226) and ofloxacin (9.7%, 22/226). The frequency of total adverse events from fluoroquinolone-containing anti-tuberculosis medication was 22.6%, whereas fluoroquinolone-related adverse events were estimated to be 2.2% (5/226). The most common fluoroquinolone-related adverse events were gastrointestinal problems (3.5%, 8/226). There were no significant differences in the treatment success rate between the fluoroquinolone and fluoroquinolone-naïve groups (78.3% vs. 78.4%, respectively). CONCLUSION: At our institution, fluoroquinolones are commonly used for the treatment of both multidrug-resistant tuberculosis and susceptible tuberculosis, especially as a substitute for adverse event-related drugs. Considering the low adverse event rates and the comparable treatment success rates, fluoroquinolones seem to be an invaluable drug for the treatment of tuberculosis.
Drug Resistance
;
Fluoroquinolones
;
Humans
;
Korea*
;
Levofloxacin
;
Ofloxacin
;
Retrospective Studies
;
Tertiary Care Centers
;
Tertiary Healthcare*
;
Tuberculosis*
;
Tuberculosis, Multidrug-Resistant
9.Surgical treatment of atricular node reentrant tachycardia-2 cases report.
Jeong Seob YOON ; Jong Beum KWEON ; Chi Kyung KIM ; Moon Sub KWACK ; Se Wha KIM ; Wook Sung CHUNG ; Soon Jo HONG
The Korean Journal of Thoracic and Cardiovascular Surgery 1993;26(5):403-408
No abstract available.
10.A Case of Interruption of Aorta with Patent Ductus Arteriosus.
Jae Kyung CHOI ; Chang Hoon JANG ; Ho Joong YOON ; Jong Mok YANG ; Wook Sung CHUNG ; Seung Suk CHUN ; Jae Hyung KIM ; Kyu Bo CHOI ; Soon Jo HONG
Korean Circulation Journal 1991;21(5):914-918
Interruption of the aortic arch is an uncommon congenital cardiovascular malformation invariably accompanied by other cardiovascular anomalies. This carries a 76% mortality rate in the first month of life. We recently experienced a case of interruption of the aortic arch with patent ductus arteriosus in a 21-year-old man with systolic murmur. he did not showed any other symptoms or signs. Cardiac catheterization with angiography showed interruption of the aortic arch with many systemic arterial collaterals and patent ductus arteriosus.
Angiography
;
Aorta*
;
Aorta, Thoracic
;
Cardiac Catheterization
;
Cardiac Catheters
;
Ductus Arteriosus, Patent*
;
Humans
;
Mortality
;
Systolic Murmurs
;
Young Adult